ResMed Stock Forecast
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 230.05 -0.03%
RMD analyst consensus
Consensus (20 analysts)
buy
Avg. price target
$250.22+8.77%
- Strong buy 2
- Buy 7
- Hold 10
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 20 Wall Street analysts covering ResMed (2026-10-07), 9 rate the stock a buy or strong buy, 10 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $250.22, with a high estimate of $320.00 and a low estimate of $175.00. The average target implies upside of 8.8% from the current price of $230.05.
The spread between the highest and lowest targets is 82.9%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for RMD.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 10% |
| Buy | 7 | 35% |
| Hold | 10 | 50% |
| Sell | 1 | 5% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $175.00 | -23.93% |
| Average target | $250.22 | +8.77% |
| High target | $320.00 | +39.10% |